Skip to content
Study details
Enrolling now

The Long COVID-19 Wearable Device Trial

Scripps Translational Science Institute
NCT IDNCT05741112ClinicalTrials.gov data as of Apr 2026
Target enrollment

100,500

Study length

about 2 years

Ages

18+

Locations

1 site in CA

What this study is about

This trial is testing a wearable device to see if it can help manage symptoms of Long COVID-19 and post-exertional malaise. Participants will use the device, either one they already own or one provided by it, along with educational materials.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Wearable device

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Primary Objective 1:Assess the effect of study-provided devices and enhanced educational materials to manage Long COVID-19 symptom severity, compared to general educational materials alone using data from participants survey responses., Primary Objective 2: Collate a unique longitudinal dataset combining patients' demographics, symptoms, symptom severity, quality of life, and sensor data including sleep, activity, heart rate, heart rate variability, and Body Battery.

Secondary: Secondary Objective: Assess the longitudinal impact of sustained use of the study-provided devices and enhanced educational materials on symptom severity.

Body systems

Infectious